This protocol is judged by an institutional critique board, an unbiased group that critiques any scientific trials involving people. If a analyze consists of a Routine I drug, as soon as the board approves the protocol as ethical, the scientists have to make an application for an investigational new drug (IND) selection from your FDA.The result set